Tag | Content |
---|
EnhancerAtlas ID | HS105-77935 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr8:56875710-56876660 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
GFI1 | MA0038.2 | chr8:56876422-56876434 | TGCTGTGATTTG | - | 6.52 | Gfi1b | MA0483.1 | chr8:56876422-56876433 | TGCTGTGATTT | - | 6.62 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09229 | chr8:56872796-56876558 | CD14 | SE_10861 | chr8:56867409-56878487 | CD20 | SE_53331 | chr8:56873279-56876338 | Spleen | SE_58907 | chr8:56872805-56941745 | Ly3 | SE_61351 | chr8:56875318-56932483 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH08I055963 | chr8 | 56876027 | 56876489 |
|
Enhancer Sequence | GCTATGAACA ATGCGCTGCA CATTTTTGTG CCTCATTTTT GTGCTGATGC AAGCATGCAT 60 GAGCTCTAGG GTGAGTGGGA GTGGATTTGC TGGATCGTAA GGTGTATGAA TCTTCAGCTC 120 TTCTAAGTTA TTGCCAACTT ATTTTGCAAA GTGCTGGTCC CAGCTTAAGA TTCTCACCAG 180 CAATATGCCA GTCCCCACGT CCCCTTTCCT GACTAGCAGA GCTGTACTTA GAGAGATGTG 240 GGCCCCAAGG CAGCACAGGC AGTGGGTGGT TATCCGGAAG GAAGTGTGCA CTCAGCATCC 300 TTCATGGACA CCTTGGATGT TGTCACAGAA GCTCTGCAAT TGAATTTCAG TGATGCTCAG 360 CAAAGAACAC AGAATGAGGC CTAGGGCAGC TGCTCCAGAG TCCCTCCCAA GGGGCAGGTG 420 CTCATCAGCA CTTGATATTA CCAGACTTTA AAAATTTTTG CTGAGCTCGG CAGTGGTTTC 480 TCATGACTTT ATTTGCATTT CTCTGGTTGC TAATAAGATT GAGTACTTTT CACGTGTTTA 540 TTACTCATAT GAATTTCTTC TTTTGAAATG CCCTTCCAAG TCTTTGCCTA TTTCTTCTGA 600 TTTTTCTTAT TGATTTGTAA GAATTCTTTC TATATCCTGG ATGCAAGTTC CTTGCAGTTA 660 TATGTATCAT ATAGTTTATG TATTTTCATC TATTTTATAT CATGTATTTT CCTGCTGTGA 720 TTTGCTATGG ATATGCTCAT GTAACTTAGG GTTAGAGTTA GGGCTGGGGT TAAGGTTAGG 780 GTTTATAAAC GTTAAAAAAT TTATAATAAA ACCTTTTTGA TTTAAATGTA ATATTAAAAG 840 GCTTTTGTTG GTGGAATGTA CTTTACAATA ACTCTTAAGA TCTACAGAAA AGGCCATATT 900 GCTTGTAATT ATGCATTTAG ATGTCAGAAC AATTTAATAT ATTCATAATT 950
|